WHAT WE DO

Seamless support for patients and families

Clincierge® enables patients to connect more effectively with clinical trials of new medicines. We reduce barriers to trial participation making it possible for patients and others to gain faster access to potentially useful new treatments.

Our unique services – including individualized travel and housing logistics, payment/reimbursement systems and on-going patient, family and caregiver support – reduce the anxiety and out-of-pocket expense that patients and their families too often face when participating in clinical trials. We address special patient needs and the demands that complex trial designs place on them and their families, building custom solutions to specific study-related problems as required. From the time a patient enrolls in a Clincierge-supported study until its completion, our multi-lingual, in-country “clincierges” provide seamless, personalized support for patients, their families and caregivers, communicating closely with them each step of the way.

By helping patients, we help trial sponsors, CROs and research institutions manage the cost and time of clinical trials. Clincierge’s value-added services not only enhance patient recruitment and improve retention, they also relieve clinical research associates, clinical investigators and other study sponsor and trial site personnel from time-consuming patient logistics, enabling them to focus on patient care and the study itself. We reduce trial administrative costs and increase the timeliness of payments by managing such financial details via our efficient online payment platform.

PATIENTS VOICE CONCERNS ABOUT THE PHYSICAL AND EMOTIONAL STRAIN, AND THE UNEXPECTED COSTS AND BURDEN OF COORDINATION OF TRAVEL AND OVERNIGHT STAYS, REQUIRED TO PARTICIPATE IN A CLINICAL TRIAL.

EXPANDING GLOBAL COVERAGE WITH EACH NEW TRIAL
Clincierge currently supports trials in 30 countries and 23 languages around the world, we are bringing new service areas on-line and expanding service capabilities to meet the unique needs of each trial and the participating patients.
map

Languages

Bulgarian
Chinese (Hong Kong)
Dutch
English
Filipino
French
German
Greek
Indonesian
Italian
Japanese
Korean
Malay
Malaysian
Mandarin
Palauan/English
Portuguese
Quebecois
Spanish
Swedish
Taiwanese
Tetum
Turkish